---
category: news
title: "Renalytix Reports Financial Results for Second Quarter of Fiscal Year 2022"
excerpt: "Renalytix plc (NASDAQ: RNLX) (LSE: RENX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and advance value-based care,"
publishedDateTime: 2022-03-31T11:03:00Z
originalUrl: "https://apnews.com/press-release/GlobeNewswire/covid-technology-science-health-business-b0f4f68c856590d203f963d2c72f6455"
webUrl: "https://apnews.com/press-release/GlobeNewswire/covid-technology-science-health-business-b0f4f68c856590d203f963d2c72f6455"
type: article
quality: 22
heat: -1
published: false

provider:
  name: Associated Press
  domain: apnews.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://apnews.com/images/PaidContent3.png"
    width: 700
    height: 450
    isCached: true

related:
  - title: "HC Wainwright Reiterates Buy Rating for Renalytix AI (NASDAQ:RNLX)"
    excerpt: "Renalytix AI (NASDAQ:RNLX – Get Rating)‘s stock had its “buy” rating restated by equities researchers at HC Wainwright in a research note issued on Friday, TipRanks reports. They presently have a $30."
    publishedDateTime: 2022-04-03T08:10:00Z
    webUrl: "https://www.etfdailynews.com/2022/04/03/hc-wainwright-reiterates-buy-rating-for-renalytix-ai-nasdaqrnlx/"
    ampWebUrl: "https://www.etfdailynews.com/2022/04/03/hc-wainwright-reiterates-buy-rating-for-renalytix-ai-nasdaqrnlx/amp/"
    cdnAmpWebUrl: "https://www-etfdailynews-com.cdn.ampproject.org/c/s/www.etfdailynews.com/2022/04/03/hc-wainwright-reiterates-buy-rating-for-renalytix-ai-nasdaqrnlx/amp/"
    type: article
    provider:
      name: ETF Daily News
      domain: etfdailynews.com
    quality: 57
    images:
      - url: "https://www.marketbeat.com/scripts/RatingsChart.ashx?Prefix=NASDAQ&Symbol=RNLX"
        width: 600
        height: 385
        isCached: true
  - title: "Here's what to expect from Renalytix AI's earnings report"
    excerpt: "Renalytix AI reveals earnings for Q2 on March 31.Wall Street predict expect Renalytix AI will release losses per share of $0.160.Go here to track"
    publishedDateTime: 2022-03-30T13:07:00Z
    webUrl: "https://markets.businessinsider.com/news/stocks/renalytix_ai_1-q2-earnings-preview-stock-1031318920"
    type: article
    provider:
      name: Business Insider
      domain: businessinsider.com
    quality: 47
  - title: "What Wall Street expects from Renalytix AI's earnings"
    excerpt: "Renalytix AI will release figures for the most recent quarter. Wall Street predict expect Renalytix AI will release losses per share of $0.080. Follow Renalytix AI stock price in real-time here. On March 31,"
    publishedDateTime: 2022-03-30T13:07:00Z
    webUrl: "https://markets.businessinsider.com/news/stocks/renalytix_ai-stock-quarter-earnings-preview-q2-1031318919"
    type: article
    provider:
      name: Business Insider
      domain: businessinsider.com
    quality: 47

secured: "SUsSb3+gbH8dzCDZlAuAo7l3LBBUhyZuiOJndge8vLEkdSO9B42ZxYczJEbRXFd0Ipu6zj+wtThMvKte6mycLdQCUvwTnXie7aeDjcR76GfOcdi0pEeO6LjPWT+UxjNFfLvovg6tutqGtPs+NYm4PoBY3cZzsEhH2lP+FVCXmeOYfT7AHpVe6R27i6v8/9BOH/3Aw/hNaKaYyFqt91BzbYMYAVxYYS4uc/qsxJ+jyDisIA5qcoxs1PEH5DPyVrddSrmYktaa3viQ20IQqP/RGIuXxs0rLxA2hL+8m2zvSDWy03OSs8L8j52qPKdM5P6aFQW2aBVZOY4Gny3M1IinSfxmwx0D5Z5pav0eZn6sBTc=;kvc9i5ijJHD0xx2Ih/TFtA=="
---

